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http://www.lipidworld.com/content/13/1/15RESEARCH Open AccessHigh-fat diet from perilla oil induces insulin
resistance despite lower serum lipids and
increases hepatic fatty acid oxidation in rats
Tao Zhang1, Shuang Zhao1, Wei Li1, Lanzhi Ma1, Ming Ding1, Ruisheng Li2 and Yuan Liu1*Abstract
Background: The purpose of this study is to investigate the effects of a high-fat diet from perilla oil on serum lipids,
hepatic lipid metabolism and insulin sensitivity.
Methods: Male Sprague–Dawley (SD) rats were fed either a control (CT) diet or a diet high in perilla oil (HP). After
16 weeks of feeding, the serum lipids were measured, and the gene expressions involved in hepatic fatty acid
oxidation and synthesis were determined. In addition, hepatic fat deposition was detected, and insulin sensitivity
was evaluated by means of euglycemic-hyperinsulinemic clamp.
Results: Compared with the rats in the CT group, the HP-feeding significantly decreased the levels of triglyceride
(TG), total cholesterol (TCH) and HDL-cholesterol (HDL-c). HP-feeding did not change the levels of LDL-cholesterol
(LDL-c), free fatty acid (FFA), intrahepatic lipids or body weight. Moreover, the HP-feeding dramatically increased the
mRNA expressions of fatty acid oxidation markers (PPAR-alpha, CPT1A) and fatty acid synthesis markers (SREBP-1,
FASN and ACC) in the liver. The HP-feeding induced increased protein levels of CPT1A, while reducing the protein
levels of FASN and ACC in the liver. However, the glucose infusion rate significantly increased in the HP group
compared with the CT group.
Conclusions: Our data show that, in rats, excessive perilla oil intake may significantly lower serum lipids, strengthen
hepatic fatty acid oxidation, and inhibit hepatic fatty acid synthesis, but at the same time may also lead to insulin
resistance.
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Epidemiological evidence suggests that a western diet
rich in fat is associated with obesity, NALFD and insulin
resistance [1,2]. In order to investigate the effects of high
fat diet on bodies, a large number of experiments have
employed high-fat diet-induced animal models [3-5]. A
multitude of different high-fat diets have been used with
relative fat fractions between 20 and 60% energy as fat,
and the basic fat component varies between animal de-
rived fats and plant oils [6]. However, the characteristics
of the animal models induced by high-fat diets from vari-
ous fat sources are different. In our previous experiments,* Correspondence: Bj_liuyuan@163.com
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stated.semi-purified diets with fat consisting of 45.73% energy
based on animal fats and n-6 fatty acid-containing plant
oils led to obesity and NALFD, whereas diets with the
same amounts of linseed oil, which were rich in ALA
(>55% of total FA), did not [7].
Perilla is one of the richest sources of ALA. ALA and
other fatty acids may be transformed into long-chain
polyunsaturated fatty acids, such as eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA), via a series
of elongation and desaturation reactions [8]. Delta-6-
desaturase catalyzes rate-limiting enzymatic reactions in
humans. Two long-chain n-3 PUFAs (EPA and DHA)
from fish oil have been widely recognized due to their
beneficial effects on health, and are considered asLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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have shown that n-3 PUFAs play roles in resisting in-
flammation, increasing insulin sensitivity, and reducing
the incidences of obesity and cardiovascular and cere-
brovascular diseases [10-12]. In rodents in vivo, n-3
long-chain-PUFA has been shown to have a protective
effect against insulin resistance [13]. In general, dietary
studies evaluating n-3PUFA efficacy in different model
systems rely on low doses [14], in which ~5% fish or
flaxseed oil was used as intervention (corresponding to
approximately 2–6% of the total energy as n-3PUFAs).
A few studies have tested the effects of n-3PUFAs at
higher doses on functional endpoints. Very little is
known about the effects of high doses of perilla, which
may have a unique therapeutic function, but may also
exert negative side effects, thus raising potential safety is-
sues for the general public. The purpose of the current
study is to examine the serum lipids, hepatic fat depos-
ition, insulin resistance, hepatic gene expression involving
fatty acid oxidation and synthesis in HP-induced rats.Figure 1 Weight and feed intake. A, weight; B, feed intake; C, energy int
n = 8 Rats per diet. Significance during the HP compared to CT is indicatedResults
Body weight and food consumption
Figure 1 summarizes the animal characteristics after 16
weeks of diet. There was no difference in the body
weights found between the HP and CT groups. The CT-
fed rats took a much larger diet (P < 0.01) than the HP-
fed ones. Fat energy intake was higher (P < 0.01) in the
HP-fed rats, despite the lack of difference (P = 0.139) in
energy intake in the CT group compared with the HP
group.Serum lipids
As depicted in Figure 2, long-term HP feeding resulted
in remarkable decreases in serum TG (P < 0.01), TCH
(P < 0.01), and HDL-c (P < 0.01), compared with the
CT-fed rats. Serum FFA levels remained unchanged in
the HP-fed rats relative to the CT rats (P > 0.05). LDL-c
was calculated as previously described [15], for which
no difference was shown between the two groups.ake; D, fat energy intake. Data are mean ± standard deviation (SD),
by *P < 0.05 (Student’s t-test).
Figure 2 Indicators of serum lipids. A, triglycerides (TG), total cholesterol (TCH), high density lipoprotein cholesterol (HDL-c), low density
lipoprotein cholesterol (LDL-c); B, free fatty acid (FFA). Data are mean ± standard deviation (SD), n = 8 Rats per diet. Significance during the HP
compared to CT is indicated by *P < 0.05 (Student’s t-test).
Table 1 Relative gene expression levels of hepatic fatty
acid oxidation enzymes
Gene Relative expression P
C T H P
PPAR-α 0.321 ± 0.144 0.869 ± 0.435* <0.001
CPT1A 0.248 ± 0.105 0.46 ± 0.214* <0.001
Data are mean ± standard deviation (SD), n = 8 Rats per diet. Significance
during the HP compared to CT is indicated by *P < 0.05 (Student’s t-test).
Zhang et al. Lipids in Health and Disease 2014, 13:15 Page 3 of 9
http://www.lipidworld.com/content/13/1/15HP-feeding increases hepatic fatty acid oxidation
The expressions of the PPAR-α and CPT1A genes were
analyzed in the rats by means of real-time PCR. As
depicted in Table 1, a statistically significant up-
regulation of PPAR-α and CPT1A mRNA expression
was observed in the HP group, compared with the CT
group (P < 0.01). The effects of the long-term high-
perilla diet on the PPAR-α and CPT1A protein levels
were assessed. Consistent with the RNA data, the
amount of CPT1A protein increased in the HP group,
relative to the CT group. However, the PPAR-α protein
did not change (as depicted in Figure 3).
HP-feeding induces changes in hepatic lipid synthesis
gene expression
The real-time PCR analysis shows that the mRNA con-
tent of SREBP-1, a key transcription factor involved in
the regulation of lipogenesis, was higher in the livers of
the HP-fed rats than the CT rats (Table 2). However,
there were no differences in the SREBP-1 protein levels
between the two groups. The mRNA levels of FASN and
ACC, two major enzymes involved in fatty acid synthe-
sis, significantly increased in the HP-fed rats, relative to
the CT rats. However, the protein levels of FASN and
ACC exhibited reverse results. As depicted in Figure 4,
the amounts of FASN and ACC protein decreased in the
HP group compared with the CT group.
Rats fed with high-dose perilla diet display insulin
resistance
As shown in Figure 5, the insulin and glucose levels in the
fasted rats were similar between the CT and HP groups.
After application of the euglycemic-hyperinsulinemic
clamp, it was found that the HP-fed rats exhibited insulin
resistance after fed for 16 weeks, as shown by the higher
glucose infusion rate upon extron insulin stimulation in
comparison with the CT rats.Intrahepatic lipids
Histological analysis revealed that there were almost no
lipid droplets in the livers of the HP-fed rats compared
with the CT rats (Figure 6). These observations were
confirmed by the biochemical analysis, which showed
that hepatic fatty oxidation was up-regulated both in
terms of the mRNA and protein levels, and hepatic lipid
synthesis was down-regulated in the protein levels after
HP feeding.
Discussion
Being one of the richest sources of ALA, perilla oil con-
sists of 69.11% ALA. After a 16-week dietary treatment
with a diet rich in perilla oil, the level of lipids in the
serum lowered significantly and hepatic fatty oxidation
improved. In contrast, insulin sensitivity, as measured by
a euglycemic-hyperinsulinemic clamp, was decreased by
the perilla oil-rich diet.
Excessive ALA intake did not cause significant in-
creases in body weight or total body fat in the HP group
[16], which is similar to the role of EPA/DHA used to
prevent obesity and overweightness [17]. Contrarily,
after high-fat diet derived from lard or soybean oil were
fed to rats or mice, the results showed that the animals
had severe intra-abdominal fat and fat deposition, and
their body weights were much higher than those of the
control group [18-20]. These results suggest that perilla
may affect triglyceride deposition in adipose tissue and
Figure 3 Western blot of peroxisome proliferator activated receptors-α (PPAR-α, 52 kDa) and carnitine palmitoyltransferase 1A
(CPT1A, 88 kDa). PPAR-α and CPT1A levels were normalised to beta actin (42 kDa). Values are mean from three independent experiments
conducted with duplicate treatments, with standard deviations represented by vertical bars. Significance during the HP compared to CT is
indicated by *P < 0.05 (Student’s t-test).
Table 2 Relative gene expression levels of hepatic fatty
acid synthesis
Gene Relative expression P
C T H P
ACC 0.455 ± 0.153 0.989 ± 0.375* <0.001
FASN 0.145 ± 0.087 0.404 ± 0.191* <0.01
SREBP-1 0.372 ± 0.185 0.774 ± 0.327* <0.01
Data are mean ± standard deviation (SD), n = 8 Rats per diet. Significance
during the HP compared to CT is indicated by *P < 0.05 (Student’s t-test).
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kine secretion).
In the present study, the serum levels of triglycerides
and total cholesterol of rats in the HP group decreased
by 86.5 and 40.2%, respectively, compared with those in
the control group. In accord with our data, when the
mice were respectively fed a high-ALA diet (12% ALA
and 4% LA) and a high-LA diet (12% LA and 3% ALA),
the serum levels of total cholesterol of the mice fed with
the high-dose ALA decreased significantly after 35 days
of feeding [21]. Clinical trials demonstrated that patients
with metabolic syndrome had a daily ALA intake of
3.5 g/d on their body weight, and their serum levels of
triglycerides and total cholesterol decreased significantly
after six months of dietary intervention [22]. Therefore,
the data suggest taking high doses of ALA was effective
in their accepted role of lowering TG and TCH, and this
method may be used to treat patients to whom statins
are clinically not applicable. However, the n-3 PUFAs
currently used mainly originate from marine products
(EPA/DHA) [23-25], while few studies have focused on
ALA. In addition, the serum levels of high-density lipo-
protein cholesterol in the HP group were significantly
lower than those in the control group. The reason for
this result may be that peripheral cholesterol does not
require being transported to the liver, due to cholesterol
reduction.
Liver plays a central role in maintaining energy bal-
ance and contributing to energy storage in the fed state.
The results of the present study show that, compared
with the control group, the hepatic mRNA levels of
PPAR-α and CPT1A in the HP group increased by 171
and 85%, respectively, with a significant increase in hep-
atic CPT1A protein expression. However, no difference in
hepatic PPAR-α protein expression was shown, suggesting
that the high-perilla intake enhanced β-oxidation. 3 T3-L1
cells were treated with ALA, and by DNA microarray ana-
lysis the results show that a 1.7-fold increase occurred in
the CPT-1a gene expression [26]. In animal experiments,it has been proven that ALA may enhance fatty acid oxi-
dation. When rats were fed with flaxseed oil and perilla
oil, the mRNA expression levels of hepatic CPT-I and
CPT-II significantly increased, but no effect was shown in
terms of fatty acid synthesis [27]. Gonzalez-Manan D. fed
rats with chia (Salvia hispanica) and rosa mosqueta (Rosa
rubiginosa) rich in ALA, and found significant increases
in the PPAR-α transcript level and CPT1A protein expres-
sion level after 21 days of feeding [28]. In the present
study, the mRNA expressions of hepatic SREBP-1, FASN
and ACC of rats in the HP group were significantly higher,
while the protein expressions of FASN and ACC were sig-
nificantly lower, compared with those of the control
group. In addition, the SREBP-1 protein expression
showed no significant difference between the two groups.
These results indicate that the high-dose ALA inhibited
fat synthesis by regulating the translation pathway.
SREBP-1 has been found to be a positive transcriptional
regulator of the cytosolic lipogenic enzymes, which work
in sequence to citrate carrier (CIC). Direct evidence was
provided that PUFA decrease CIC gene promoter activity,
the CIC transcriptional suppression by PUFA was clearly
mediated by the SRE/SREBP-1 regulatory system as its ef-
fects on CIC promoter-driven luciferase activity was abol-
ished by mutations in the SRE site of the CIC gene
[29-31]. However, the rats in the HP group were given a
long-term diet with high energy, and excessive fat depos-
ition did not occur in the liver, due to an increase in fatty
acid oxidation and a decrease protein expression of key
Figure 4 Western blot of Sterol Regulatory element binding protein-1 (SREBP-1, 65 kDa), Fatty acid synthase (FASN, 273 kDa) and
acetyl coenzyme A carboxylase (ACC, 265 kDa) were normalised to beta actin (42 kDa). Values are mean from three independent
experiments conducted with duplicate treatments, with standard deviations represented by vertical bars. Significance during the HP compared
to CT is indicated by *P < 0.05 (Student’s t-test).
Figure 5 Insulin sensitivity. A, fasting serum glucose (FSG); B, fasting insulin (FINS); C, glucose infusion rat. Data are mean ± standard deviation (SD),
in (A) and (B) n = 8 rats per diet, in (C) n = 4 rats per group. Significance during the HP compared to CT is indicated by *P < 0.05 (Student’s t-test).
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Figure 6 Oil red O staining of liver (original magnification, 200×).
Table 3 Dietary energy levels and energy percentages
Group KJ/g Fat: Protein: Carbohydrate
C T 15.70 10.31%: 20.20%: 69.49%
H P 19.35 45.73%: 19.67%: 34.59%
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the observation, obese Zucker rats were fed a diet contain-
ing 4% ALA, and hepatic fat accumulation was also sig-
nificantly inhibited after one month of feeding [32].
In the present study, the mass proportion of ALA in
the high-fat diet was 15.74%, and the data from the 16-
week clamp experiment show a significant reduction in
insulin sensitivity in the HP group. In our previous stud-
ies, rats were fed a high-fat diet with the same propor-
tion of perilla, and their insulin sensitivity indexes also
decreased significantly after eight weeks of feeding [33].
There have been very few studies in this area to directly
compare our data to. However, in terms of application in
humans, one study found that an intake of high-dose
long-chain n-3 PUFAs (5–8 g/d) increased the blood
glucose level in patients with type II diabetes [34]. The
reason for this insulin resistance caused by long-term
excessive ALA may be that the activity of fatty acid
β-oxidation leads to acetyl-CoA accumulation, then pyru-
vate dehydrogenase activity inhibited by excessive intra-
cellular acetyl-CoA causes citric acid accumulation. As a
potential inhibitor of phosphofructokinase, citric acid
blocks glucose oxidation in the initial stage, resulting in
a decrease in the glucose transportation rate of GLUT4
[35]. Many studies have shown that an excessive satu-
rated fat intake caused an increase of FFA, and elevated
FFA had a “toxic” effect on the body, causing damage to
the pancreatic beta cell function, promoting cell apop-
tosis, and resulting in impaired glucose-stimulated in-
sulin secretion [36]. Male Sprague–Dawley rats were
fed a chow-diet or a diet high in saturated fat or PUFA
(derived from lard and coconut oil or pufa derived from
safflower oil). The results show that after 8 weeks, both
high-fat diets increased the plasma FFA by 30% [37].
However, excessive ALA intake did not cause elevated
serum FFA levels of the rats in the HP group.After long-term excessive perilla intake, no significant
changes were shown in the body weight, hepatic fat de-
position or intra-abdominal fat of the rats. In addition, a
significant reduction was seen in the serum lipid level,
as well as significant increases in the expressions of key
enzymes in fatty acid oxidation, along with significant
decreases in the protein expressions of key enzymes in
fatty acid synthesis. However, the experimental results of
the insulin sensitivity reduction will incite interest in re-
searchers studying ALA dosage. More studies regarding
the functions and mechanisms of ALA in the bodies of
animals and their verification in the human body must
be conducted in order to determine the most effective
doses of ALA for prevention and treatment.
Conclusions
We have observed that excessive perilla oil intake may
significantly lower serum lipids, strengthen hepatic fatty
acid oxidation, and inhibit hepatic fatty acid synthesis,
but lead to insulin resistance in rat. Further studies are
needed to elucidate the precise mechanism of ALA in
the bodies of animal and their verification in the human
body must be conducted in order to determine the most
effective dose of ALA for prevention and treatment.
Materials and methods
Animals and diet
This study was conducted in conformity with the pol-
icies and procedures of the Institutional Animal Care
Table 5 Types and levels of dietary fatty acids
Fatty acids Fatty acids in diet, g/100 g







Table 6 Primers for analysis of transcription level of gene
expression
Gene Accession Primer Tm, °C Amplicon
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week-old male Sprague–Dawley (SD) rats were obtained
from the Laboratory Animal Centre of the Academy of
Military Medical Sciences(Dong da jie 20th, Beijing,
China). The rats were housed in groups of four per cage
at 22°C with a 12 h light/dark cycle (light period: 6:00–
18:00 h) and given free access to diet and water. After
acclimatization at the facility for one week, the rats were
given ad libitum access to one of two diets for 16 weeks
(n = 8 for each group), i.e. the control (CT) diet or a diet
high in perilla oil (HP). As listed in Table 3, the control
diet consisted of 20.2% calories from protein, 10.31% cal-
ories from fat, and 69.49% calories from carbohydrates.
The HP diet consisted of 19.67% calories from protein,
45.73% calories from perilla, and 34.6% calories from
carbohydrates. The compositions of the diets are listed
in Table 4. The fatty acid compositions of the diets are
listed in Table 5.
Serum parameters
Upon completion of the experiments, all rats were
weighed and blood was collected from the anesthetized
animals into blood collection tubes after an overnight
fast (12 h). After standing for 30 min, the serum was
prepared by centrifugation of blood at 1000 × g for
10 min at 4°C and stored at −80°C until analysis. Serum
triglyceride (TG), total cholesterol (TCH), high density
lipoprotein-cholesterol (HDL-c) and glucose (GLU) were
measured by means of enzymatic and colorimetric
methods, using assay kits (Sinopharm Chemical ReagentTable 4 Feed formulas
C T H P
Ingredients g/100 g Ingredients g/100 g
Corn starch 52 Corn starch 20
Maltodextrin 3.2 Maltodextrin 10
Sugar 10 Sugar 10
Soybean Oil 4.3 Perilla Oil 23.5
Casein 19.0 Casein 22.7
Powdered Cellulose 4.7 Powdered Cellulose 5.7
MgO 0.085 MgO 0.102
NacL 0.35 NacL 0.42
Potassium Citrate 0.9 Potassium Citrate 1.08
KSO4 0.5 KSO4 0.6
Dicalcium Phosphate 2.4 Dicalcium Phosphate 2.88
Mineral Mix 1.625 Mineral Mix 1.95
Vitamin Mix 0.05 Vitamin Mix 0.06
Calcium Carbonate 0.3 Calcium Carbonate 0.36
DL-Methionine 0.35 DL-Methionine 0.42
Choline Bitartrate 0.2 Choline Bitartrate 0.24
Yellow Dye 0.001 Red Dye 0.001Beijing Co., Ltd, China). Free fatty acid (FFA) and insulin
(INS) concentration were determined using rat FFA and
insulin ELISA kits (Novateinbio INC), respectively. LDL
cholesterol was calculated according to the method of
Friedewald et al. [15].
Real-time quantitative PCR
cDNA was prepared by reverse transcription of six micro-
grams of total RNA using the Kit Reverse transcription
System. Real-time qPCRs were performed with an IQ5 in-
strument and software. RNA levels were determined by
analyzing the changes in SYBR Green Ifluorescence
during PCR, according to the manufacturer's instruc-
tions. β-actin was amplified in parallel, and the resultsno. size,bp

























ACTIN NM_031144.2 F 5'–CCC ATC TAT GAG
GGT TAC GC-3'
50 150
R 5'-TTT AAT GTC ACG
CAC GAT TTC-3'
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PCR product was confirmed by electrophoresis on a
2.5% agarose gel stained with ethidium bromide. The
purity of the amplified PCR products was determined
by melting point analysis. The primers and gene details
are summarized in Table 6.
Immunoblotting
Total proteins were prepared from livers (~100 mg), as
previously described [38]. The proteins were resolved by
SDS-PAGE at 80 V for 30 min, followed by 120 V for
100 min, then transferred to polyvinylidene difluoride
membranes at 250 mA for 2 h. Membranes were
blocked for 1 h at room temperature, with PBS contain-
ing 0.1% tween and 5% skim milk powder, and incubated
with mouse monoclonal anti-PPARα antibodies (1:5000,
52 kDa), mouse monoclonal anti-CPT1A antibodies
(1:5000, 88 kDa), mouse monoclonal anti-SREBP-1 anti-
bodies (1:5000, 65 kDa), rabbit monoclonal anti-fatty
acid synthase antibodies (1:5000, 273 kDa), rabbit mono-
clonal anti-acetyl coenzyme A carboxylase antibodies
(1:5000, 265 kDa), and mouse monoclonal anti-beta
actin antibodies (1:5000, 42 kDa) (all antibodies were
purchased from Abcam Inc., USA), overnight at 4°C,
then washed for 3 × 10 min with PBS containing 0.1%
tween. After incubation with the appropriate secondary
antibody for 1 h at room temperature, the membranes
were washed for 3 × 10 min with PBS. Then the bands
were visualized by ECL and quantified densitometry.
Euglycemic-hyperinsulinemic clamp study
After 16 weeks of feeding, the clamp was done. The rats
were anesthetized with isoflurane (Sinopharm Chemical
Reagent Beijing Co., Ltd, China) after fasting overnight.
The left common carotid artery and right jugular vein
were catheterized as previously described [39]. The
clamps were then performed 4–5 d later after complete
recovery of the rats from the operation. Rats (n =4 per
group) fasted for 12 h, were infused with human insulin
(Humulin R, Novo Nordisk) into the venous circulation,
at a rate of 4 mU · kg-1 min-1 for 2 h. Throughout the
infusion, the carotid artery was assessed every 10 min
using a blood glucose meter(One Touch Uitra, Lifescan).
Titration of glucose continues until stable glucose read-
ings are achieved. Stable glucose levels over a time
course of a minimum of 30 min. Glucose levels and glu-
cose infusion rates during this stable period are recorded
and reported. Results provide an index of whole body in-
sulin sensitivity.
Oil red O staining
For the detection of neutral lipids, portions of liver were
rapidly frozen in liquid nitrogen and embedded in
Tissue-Tek. 5 μm cryosections were mounted on themicroscope slides and air-dried for 2 h. After fixation in
4% neutral formaldehyde for 10 min, sections were
stained with oil red O, with 0.5% oil red O dissolved in
propylene glycol for 10 min at 60°C. The sliced sections
were then counterstained.
Statistical analysis
The results are presented as means ± standard error.
The differences among two diet groups were analyzed by
Student’s t-test within the SAS version 9.0 statistical
package. Differences were considered to be significant at
p < 0.05.
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